Table 1.
rs3131917 | Minor allele | Minor allele frequency | Chi‐square | P corr b | OR (95% CI) | |
---|---|---|---|---|---|---|
Cases | Controls | |||||
Overall association analysis | ||||||
UK, SSc+ vs. SSc– | T | 0.48 | 0.46 | 1.16 | 0.28 | 1.06 (0.94–1.2) |
Spanish, SSc+ vs. SSc– | G | 0.48 | 0.51 | 3.6 | 0.05 | 0.9 (0.82–1) |
Meta‐analysis | 0.029 | 0.91 | ||||
Subphenotype analysis | ||||||
UK, anti–RNAP III+ vs. control | T | 0.54 | 0.46 | 6.25 | 0.023 | 1.34 (1.06–1.7) |
Spanish, PH+ vs. control | G | 0.42 | 0.51 | 7.8 | 0.005 | 0.72 (0.57–0.9) |
Spanish, PF+ vs. control | G | 0.46 | 0.51 | 3.97 | 0.04 | 0.84 (0.72–0.99) |
Shown are chi‐square test values, corrected P (P corr) values, and odds ratios (ORs) with 95% confidence intervals (95% CIs) for the genetic association of the rs3131917 single‐nucleotide polymorphism with systemic sclerosis (SSc) in a meta‐analysis of 2 independent cohorts (UK and Spanish), as well as for a subphenotype analysis of the association of rs3131917 with the anti–RNA polymerase III (anti–RNAP III) autoantibody, pulmonary hypertension (PH), and pulmonary fibrosis (PF). The minor allele and its frequencies in cases and controls are also shown. Genetic analyses were performed using Plink.
P corr values for multiple comparisons were determined by permutation analysis.